Archinard Philippe E
Chairman and Chief Executive Officer,
administration
Jacobs Hanson and Co?LLC
France
Biography
Mr. Philippe Archinard, Ph.D., has been the Chairman of Transgene SA since June 17, 2010 and its Chief Executive Officer since December 6, 2004. Mr. Archinard serves as a Scientific Director of Mérieux Alliance Group. He began his served career with bioMerieux where he held various positions for 15 years in France and the United States, including Chief Executive Officer of the U.S. operations. He as an Executive Director and Chief Executive Officer of Innogenetics N.V. from March 2000 to November 9, 2004 and also served its Managing Director. He has been a Director of Transgene SA since December 2004 and bioMérieux SA since June 10, 2010. He has been an Independent Director of ERYtech Pharma SA since April 2, 2013. He served as a Non-Executive Director of Innogenetics N.V., from November 9, 2004 to March 2005. Mr. Archinard holds a Degree in Chemical Engineering from the University of Montpellier (France) and received his PhD in Biochemistry from the University of Lyon (France) in 1985. In 1994, he completed the PMD program at the Harvard Business School (United States).
Research Interest
business